CHD is caused by plaque build up in the wall of the arteries that supply oxygen-rich blood to the heart (called coronary arteries). Plaque is made up of cholesterol deposits.¹ It narrows the arteries and decreases the blood flow to heart.

MI is a heart attack, occurs when the blood flow decreases or stops to the coronary artery of the heart, results in irreversible damage to the heart muscle due to a lack of oxygen.¹

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose.
It is used for the treatment of type 2 diabetes in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glucose control.
The usual starting dose is one tablet 2 or 3 times daily given during or after meals. After 10 to 15 days the dose should be adjusted on the basis of blood glucose measurements. The maximum recommended dose is 3 g daily.
Metformin is available in the EU under the following trade names (as a monotherapy): Dianben, Glucophage and Risidon

BMI is a person’s weight in kilograms divided by the square of height in meters.¹

A high BMI can indicate high body fatness.